Skip to main content

Conn. Bellwether Trial Verdict: Plaintiff Awarded $542K

Conn. Bellwether Trial Verdict: Plaintiff Awarded $542K

Conn. Bellwether Trial Verdict: Plaintiff Awarded $542K

Introduction

On Friday, May 17, a Connecticut jury awarded $542K over the alleged bleeding risk caused by blood thinner Pradaxa.

According to the trial, the lawsuit was filed in May 2016 alleging that the plaintiff had a 40-year history of gastroesophageal reflux disease, a condition that increases the chance of internal bleeding from Pradaxa but was still prescribed the drug without knowing the danger. The jury granted $42,464 in economic damages and $500,000 in noneconomic damages. The punitive damages against the pharmaceutical company will be decided by Connecticut Superior Court Judge Carl Schuman and could be up to $1.095 million.

There are more than 3,100 Pradaxa cases pending across the nation, including roughly 3,000 in the consolidated proceeding in Connecticut. The U.S. FDA approved drug has been reported to cause serious injuries and gastrointestinal bleeding, heart attack, stroke, brain hemorrhage, kidney bleeding, and death. In December 2017, Judge Herndon, who overlooked Pradaxa class action lawsuits, recommended a shutdown of the multidistrict litigation (MDL No. 2385) after dismissing the pending cases in the docket.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!